Moolec Science SA
Moolec Science SA (MLEC) Stock Overview
Explore Moolec Science SA’s financial performance, market position, analyst ratings, and future outlook.
MLEC Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Moolec Science SA (MLEC) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $0.85.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -33.88 and a market capitalization of 29.7M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.
Analyst Recommendations
Price Targets
Company Profile
Moolec Science SA, a science-based ingredient company, focuses on producing animal proteins in plants through Molecular Farming, a disruptive technology in the alternative protein landscape. The company's product portfolio and pipeline leverage the agronomic efficiency of used target crops, such as soybeans and peas. It operates in the United States, Europe, and South America. The company was founded in 2008 and is based in Luxembourg.
Mr. Henk Hoogenkamp Ph.D.
52
17 Boulevarrd F.W. Raiffeisen,, Luxembourg
2021